| Index | — | P/E | 17.88 | EPS (ttm) | 8.55 | Insider Own | 2.31% | Shs Outstand | 41.90M | Perf Week | 2.96% |
| Market Cap | 6.41B | Forward P/E | 13.31 | EPS next Y | 11.49 | Insider Trans | 0.10% | Shs Float | 41.49M | Perf Month | 22.07% |
| Enterprise Value | 8.99B | PEG | 1.80 | EPS next Q | 2.33 | Short Float | 5.22% | Perf Quarter | 27.03% | ||
| Income | 380.00M | P/S | 0.87 | EPS this Y | 7.19% | Short Ratio | 4.75 | Perf Half Y | 57.87% | ||
| Sales | 7.40B | P/B | 4.46 | EPS next Y | 6.18% | ROA | 7.01% | Short Interest | 2.17M | Perf YTD | 51.91% |
| Book/sh | 34.27 | P/C | 50.85 | EPS next 5Y | 9.94% | ROE | 25.89% | 52W High | 154.46 -1.00% | Perf Year | 67.11% |
| Cash/sh | 3.01 | P/FCF | 10.35 | EPS past 3/5Y | 12.69% 16.68% | ROIC | 10.94% | 52W Low | 81.08 88.59% | Perf 3Y | 41.17% |
| Dividend Est. | 1.48 (0.97%) | EV/EBITDA | 12.00 | Sales past 3/5Y | -1.95% 0.58% | Gross Margin | 12.65% | Volatility | 2.69% 3.13% | Perf 5Y | 67.08% |
| Dividend TTM | 1.48 (0.97%) | EV/Sales | 1.21 | EPS Y/Y TTM | 3.51% | Oper. Margin | 7.81% | ATR (14) | 4.21 | Perf 10Y | 127.48% |
| Dividend Ex-Date | Oct 09, 2026 | Quick Ratio | 1.20 | Sales Y/Y TTM | -0.78% | Profit Margin | 5.13% | RSI (14) | 78.74 | Recom | 2.61 |
| Dividend Gr. 3/5Y | 0.00% 0.00% | Current Ratio | 1.20 | EPS Q/Q | -17.08% | SMA20 | 10.32% | Beta | 0.25 | Target Price | 118.75 |
| Payout | 17.63% | Debt/Eq | 1.88 | Sales Q/Q | 6.27% | SMA50 | 15.00% | Rel Volume | 0.80 | Prev Close | 151.86 |
| Employees | 23,000 | LT Debt/Eq | 1.86 | Earnings | Dec 03 | SMA200 | 37.75% | Avg Volume | 446.00K | Price | 152.91 |
| IPO Date | Sep 16, 2013 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 30.39% 6.57% | Net Debt/EBITDA | 3.44 | Volume | 358,173 | Change | 0.69% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Sep-08-26 | Reiterated | Goldman Sachs | Sell | $96 → $103 |
| Sep-01-26 | Reiterated | Stifel Nicolaus | $137 → $154 | |
| Sep-01-26 | Reiterated | UBS | Neutral | $119 → $123 |
| Jun-03-26 | Reiterated | UBS | Neutral | $113 → $119 |
| Jun-01-26 | Reiterated | Stifel Nicolaus | $120 → $137 | |
| May-27-26 | Initiated | BNP Paribas | Neutral | $95 |
| Feb-12-26 | Reiterated | Goldman Sachs | Sell | $91 → $82 |
| Dec-08-25 | Reiterated | UBS | Neutral | $134 → $113 |
| Sep-10-25 | Reiterated | Jefferies | Hold | $130 → $115 |
| Sep-08-25 | Downgrade | JP Morgan | Overweight → Neutral |
Science Applications International Corporation (SAIC), a U.S.-based firm, specializes in providing a wide array of advanced technical, engineering, and comprehensive information technology (IT) solutions. Its diverse offerings span crucial areas such as specialized engineering, seamless technology integration, and vital IT modernization initiatives. The company also handles the upkeep of land-based and naval systems, offers logistics management, and develops training and simulation programs. Furthermore, SAIC delivers full lifecycle IT services, covering everything from the initial design and development to integration, deployment, ongoing management, operations, sustainment, and robust security for client IT infrastructures. This extensive portfolio also includes services like cloud migration strategies, managed IT services, infrastructure upgrades, and complete enterprise IT-as-a-service solutions. SAIC's clientele primarily consists of various U.S. government entities. These include all branches of the U.S. military—the Army, Air Force, Navy, Marines, and Coast Guard—along with Department of Defense agencies. Key civilian agencies and departments such as the National Aeronautics and Space Administration (NASA), the U.S. Department of State, the Department of Justice, the Department of Homeland Security, and numerous intelligence community organizations also benefit from its services. Established in 1969, Science Applications International Corporation maintains its headquarters in Reston, Virginia. The company previously operated as SAIC Gemini, Inc., before adopting its current name in September 2013.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2026 1/30/2026 | FY 2025 1/31/2025 | FY 2024 1/31/2024 | FY 2023 1/31/2023 | FY 2022 1/31/2022 | FY 2021 1/31/2021 | FY 2020 1/31/2020 | FY 2019 1/31/2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 7,402 | 7,262 | 7,479 | 7,444 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 6,466 | 6,383 | 6,587 | 6,572 | — | — | — | — | — | |
| Gross Profit | 936 | 879 | 892 | 872 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 359 | 332 | 319 | 369 | — | — | — | — | — | |
| Research and Development | 0 | 23 | 34 | 4 | — | — | — | — | — | |
| Other Operating Expense | 0 | 0 | 0 | -242 | — | — | — | — | — | |
| Operating Income | 578 | 524 | 539 | 741 | — | — | — | — | — | |
| Interest Expense | 135 | 135 | 140 | 120 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 14 | -12 | 7 | -1 | — | — | — | — | — | |
| Net Income Before Taxes | 457 | 377 | 406 | 620 | — | — | — | — | — | |
| Income Taxes | 77 | 19 | 44 | 143 | — | — | — | — | — | |
| Consolidated Net Income | 380 | 358 | 362 | 477 | — | — | — | — | — | |
| Net Income From Continuing Operations | 380 | 358 | 362 | 477 | — | — | — | — | — | |
| Net Income | 380 | 358 | 362 | 477 | — | — | — | — | — | |
| EPS (Recurring) | 8.63 | 7.73 | 7.23 | 8.98 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 8.63 | 7.73 | 7.23 | 8.98 | — | — | — | — | — | |
| EPS (Diluted) | 8.55 | 7.70 | 7.17 | 8.88 | — | — | — | — | — | |
| EBITDA | 749 | 661 | 686 | 882 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 17.88 | 13.22 | 15.10 | 14.38 | — | — | — | — | — | |
| Price To Sales Ratio | 0.87 | 0.64 | 0.72 | 0.91 | — | — | — | — | — | |
| Gross Margin | 12.65 | 12.10 | 11.93 | 11.71 | — | — | — | — | — | |
| Operating Margin | 7.81 | 7.22 | 7.21 | 9.95 | — | — | — | — | — | |
| Net Margin | 5.13 | 4.93 | 4.84 | 6.41 | — | — | — | — | — | |
| Shares Outstanding | 42 | 46 | 50 | 53 | — | — | — | — | — | |
| Market Capitalization | 6,422 | 4,681 | 5,414 | 6,766 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Cush C. David | Director | Sep 22 '26 | Buy | 132.50 | 1,000 | 132,500 | 1,000 | Sep 22 |
| Attili Srinivas | EVP, Civilian | Apr 09 '26 | Buy | 94.96 | 100 | 9,496 | 17,656 | Apr 13 |
| MOREA DONNA S | Director | Apr 07 '26 | Option Exercise | 77.65 | 2,876 | 223,321 | 37,397 | Apr 08 |
| DiFronzo Vincent P. | EVP,-Air Force & Comb Commands | Dec 23 '25 | Buy | 102.89 | 150 | 15,434 | 4,722 | Jan 06 |
| Attili Srinivas | EVP, Civilian | Dec 31 '25 | Buy | 101.26 | 100 | 10,126 | 13,635 | Jan 02 |
| Hageman Hilary | EVP General Counsel, Secretary | Dec 16 '25 | Buy | 100.21 | 100 | 10,021 | 19,006 | Dec 17 |
| REAGAN JAMES | Interim CEO | Dec 16 '25 | Buy | 100.17 | 1,000 | 100,165 | 26,460 | Dec 17 |
| Natarajan Prabu | EVP, Chief Financial Officer | Dec 16 '25 | Buy | 100.49 | 2,000 | 200,976 | 7,000 | Dec 16 |
| Attili Srinivas | EVP, Civilian | Oct 10 '25 | Buy | 97.35 | 100 | 9,735 | 13,535 | Oct 14 |
| Attili Srinivas | EVP, Civilian | Jun 03 '25 | Buy | 102.03 | 100 | 10,203 | 14,572 | Jun 05 |
| Graham Garth | Director | Apr 14 '25 | Buy | 116.75 | 215 | 25,101 | 7,159 | Apr 14 |
| Handlon Carolyn B | Director | Apr 07 '25 | Buy | 109.93 | 230 | 25,284 | 4,032 | Apr 08 |
| Attili Srinivas | EVP, Civilian | Apr 04 '25 | Buy | 111.75 | 100 | 11,175 | 11,636 | Apr 07 |
| MOREA DONNA S | Director | Apr 02 '25 | Option Exercise | 87.67 | 2,398 | 210,233 | 35,683 | Apr 03 |
| Tien John K Jr | Director | Apr 02 '25 | Buy | 116.50 | 215 | 25,048 | 919 | Apr 02 |